EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders
Clinical guideline published by European Association of Nuclear Medicine (EANM) on
The European Association of Nuclear Medicine (EANM) is a leading non-profit organization dedicated to advancing nuclear medicine in Europe. Established in 1985, it fosters collaboration among professionals, promotes education, and provides clinical guidelines to enhance patient care and public health.